RAC 2.12% $1.62 race oncology ltd

Ann: Race Initiates Extramedullary AML Preclinical Study, page-8

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 11,249 Posts.
    lightbulb Created with Sketch. 29637
    We know from the Israel trial that this study should produce great results.

    Note the reduction in tumour size - and this was from a single course of treatment ( normally there are two courses of treatment ).

    Screen Shot 2021-03-30 at 9.36.33 am.png
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.